Bright Minds - A Biotechnology Company in Canada

The research and development in the psychedelic front are advancing, owing to the potential of being the efficient mental health care treatment, evolving legislation and regulations along with the support of the public opinion. Owing to all such factors,...

Every once in a while, there’s news that breaks our entrenched view of what is possible. Recently, biotechnology company Bright Minds Bio announced that they are investing in psychedelic drugs to bring about positive effects in people with psychiatric...

The 2020 pandemic has already exacerbated the mental health care crisis worldwide. From the past two decades, the cases of drug overdose deaths along with the rates of suicides have already steeped to an extremely high rate. All such trends are serving...

The biotech sector has been generating many life-saving pharmaceuticals that take advantage of human genetics to deliver personalized treatments for every ailment or type of patient for several years now. As more and more businesses obtain FDA approval,...

Canada’s growing reputation as a world leader in medical and recreational cannabis research has now spilled over into psychedelics . Because of Canada’s lax regulatory environment, researchers from around the world are flocking to our country to study...

ATAI Life Sciences joined the mental health market in 2018 but is already working on various compounds for depression, anxiety, addiction, etc. Their research is based on psychedelics, but they are now also involved in the digital health space. IntroSpect...

Are you new to psychedelic stocks? Many Canadian psychedelic companies are starting to establish a significant place in the pharmaceutical industry and will be major players in the next coming years. Let’s see what these psychedelic company stocks Canada...

The psychedelic industry and the companies at the forefront of the industry are still in their early stages. But this doesn’t stop major investors like PayPal billionaire Peter from investing in biopharmaceutical companies like ATAI Life Sciences. While...

There are also plenty of cons for investors to take into consideration before investing in psychedelic company stocks though. Drugs like LSD and magic mushrooms aren't yet legal for recreational use; however, we think it's only a matter of time before...

Also, psychedelics have been associated to an elevated risk of psychosis in those who have psychotic illnesses or are predisposed to them. For these reasons, it is important to have a qualified guide present during sessions involving psychedelics. Since...